Epi-cochlioquinone A, a novel acyl-CoA : cholesterol acyltransferase inhibitor produced by Stachybotrys bisbyi

J Antibiot (Tokyo). 1996 May;49(5):409-13. doi: 10.7164/antibiotics.49.409.

Abstract

A novel acyl-CoA : cholesterol acyltransferase (ACAT) inhibitor, designated epi-cochlioquinone A has been isolated from the fermentation broth of Stachybotrys bisbyi SANK 17777. The molecular formula, physicochemical properties, NMR spectroscopic analysis and X-ray crystallographic analysis revealed that this compound was a stereoisomer of cochlioquinone A, which has been previously reported as a nematocidal agent. It inhibited ACAT activity in an enzyme assay using rat liver microsomes with an IC50 value of 1.7 microM. However, it showed about 10-fold less potent inhibitory effect on plasma lecithin cholesterol acyltransferase (LCAT) than on ACAT. In addition, it inhibited in vivo cholesterol absorption in rats by 50% at 75 mg/kg.

MeSH terms

  • Animals
  • Antinematodal Agents
  • Benzoquinones / chemistry
  • Benzoquinones / isolation & purification*
  • Benzoquinones / pharmacology
  • Fermentation
  • Male
  • Microsomes, Liver / drug effects
  • Molecular Structure
  • Rats
  • Rats, Sprague-Dawley
  • Stachybotrys
  • Stereoisomerism
  • Sterol O-Acyltransferase / antagonists & inhibitors*

Substances

  • Antinematodal Agents
  • Benzoquinones
  • cochlioquinone A
  • Sterol O-Acyltransferase